Skip to main content

Table 1 The assessment schedule

From: Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)

   Chemotherapy (cycles)
  Pre-treatment 1 2 3 4 5 6 7 8
Performance status
Blood test
Hand foot syndrome  
Adverse events  
Self report (adverse evens)  
Self report (self-adherence)  
Dose of chemotherapy  
Postponement of chemotherapy  
Discontinuation of chemotherapy